Wednesday, June 10, 2026

Patent intelligence · KR

KR 20230116805

가도테리돌 제조를 위한 제조 방법

granted A61K 49/ 10 A I
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 17
Applicant portfolio 25
Patent details — KR 20230116805

Quick answer

KR 20230116805 (가도테리돌 제조를 위한 제조 방법) is held by BRACCO IMAGING SPA [IT]. Status: granted. Granted Aug 4, 2023. Expires Jul 30, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
CPC classes
A61K 49/ 10 A I

More from BRACCO IMAGING SPA [IT]

Related pharmaceutical patents in our USPTO index.

  1. CN 119365549

    Fluorescent probe targeting CA-IX

    BRACCO IMAGING SPA · Expires Jan 19, 2045

    granted
  2. CN 119343336

    1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents

    BRACCO IMAGING SPA · Expires Jan 16, 2045

    granted
  3. CN 119325492

    Fluorescent probe targeting CA-IX

    BRACCO IMAGING SPA · Expires Jan 12, 2045

    granted
  4. CN 118401500

    Process for preparing mixtures of dimeric macrocyclic intermediates comprising gadolinium complexes

    BRACCO IMAGING SPA · Expires Jul 21, 2044

    granted
  5. US 2024131199

    PH RESPONSIVE CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA [IT] · Expires Apr 20, 2044

    granted
  6. KR 20240034693

    이량체 조영제의 제조

    BRACCO IMAGING SPA [IT] · Expires Mar 9, 2044

    granted
  7. US 2023312523

    NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA [IT] · Expires Sep 30, 2043

    granted

Frequently asked questions

What is US patent 20230116805?

KR 20230116805 (가도테리돌 제조를 위한 제조 방법) is held by BRACCO IMAGING SPA [IT]. Status: granted. Granted Aug 4, 2023. Expires Jul 30, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.

Who owns KR 20230116805?

BRACCO IMAGING SPA [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.

When does KR 20230116805 expire?

Our index shows an expiration date of Jul 30, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.